CLEREZO Trademark

Trademark Overview


On Wednesday, May 18, 2011, a trademark application was filed for CLEREZO with the United States Patent and Trademark Office. The USPTO has given the CLEREZO trademark a serial number of 79100187. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, May 18, 2021. This trademark is owned by ThromboGenics NV. The CLEREZO trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemical preparations and substances for use in the manufacture of pharmaceutical products and medicines

Pharmaceutical preparations and substances for the treatment or prevention of cancer, diabetes, blood disorders and cardiovascular diseases; sanitary preparations for medical purposes; medicines for human purposes, namely, for treating or preventing oncological disorders and diseases, diabetes, gastrointestinal disease, blood disorders, and cardiovascular diseases, ophthalmic medicines and surgical fluids; pharmaceutical preparations, substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical eye drops
clerezo

General Information


Serial Number79100187
Word MarkCLEREZO
Filing DateWednesday, May 18, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, May 18, 2021
Registration Number4137469
Registration DateTuesday, May 8, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2012

Trademark Statements


Goods and ServicesChemical preparations and substances for use in the manufacture of pharmaceutical products and medicines
Goods and ServicesPharmaceutical preparations and substances for the treatment or prevention of cancer, diabetes, blood disorders and cardiovascular diseases; sanitary preparations for medical purposes; medicines for human purposes, namely, for treating or preventing oncological disorders and diseases, diabetes, gastrointestinal disease, blood disorders, and cardiovascular diseases, ophthalmic medicines and surgical fluids; pharmaceutical preparations, substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical eye drops

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 14, 2018
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 14, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxurion NV
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressBE

Party NameThromboGenics NV
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressBE

Party NameThromboGenics NV
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressBE

Trademark Events


Event DateEvent Description
Sunday, December 12, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, December 12, 2021DEATH OF INTERNATIONAL REGISTRATION
Saturday, November 30, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, September 4, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, September 4, 2019INVALIDATION PROCESSED
Wednesday, August 14, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, June 13, 2019CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, December 14, 2018CANCELLED SECTION 71
Friday, September 28, 2018NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 4, 2013NEW REPRESENTATIVE AT IB RECEIVED
Sunday, November 25, 2012NOTIFICATION PROCESSED BY IB
Sunday, November 18, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, October 22, 2012FINAL DISPOSITION NOTICE SENT TO IB
Monday, October 22, 2012FINAL DISPOSITION PROCESSED
Wednesday, August 8, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 8, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, February 21, 2012PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 8, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 1, 2012NOTICE OF PUBLICATION
Tuesday, January 17, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, January 14, 2012ASSIGNED TO LIE
Monday, December 26, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 22, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 22, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 22, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 8, 2011ASSIGNED TO EXAMINER
Saturday, September 24, 2011REFUSAL PROCESSED BY IB
Tuesday, September 6, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 6, 2011REFUSAL PROCESSED BY MPU
Saturday, September 3, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 2, 2011NON-FINAL ACTION WRITTEN
Monday, August 29, 2011ASSIGNED TO EXAMINER
Thursday, August 11, 2011APPLICATION FILING RECEIPT MAILED
Sunday, August 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 4, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB